Bill
HR 135
Urges federal leaders to take all actions to ensure free, universally available COVID-19 vaccines for everyone in the U.S., regardless of income or status.
Status: Introduced September 2, 2025; referred to the Committee on Government Operations
Classification: House resolution (non‑binding)
Primary sponsors / authors (as recorded in the introduced text): Representatives Laurie Pohutsky, McFall, Arbit, Weiss, Rheingans, Martus (and additional cosponsors listed in the record)
Note: The legislative packet provided includes multiple unrelated documents labelled “HR 135” from different jurisdictions and topics. This summary focuses on the House Introduced Resolution titled “A resolution to urge the United States Congress, the President of the United States, and the Secretary of the United States Department of Health and Human Services to take all necessary actions to support and ensure the provision of free and accessible COVID‑19 vaccines for all.”
Purpose and intent
- To urge the President, the U.S. Congress, and the HHS Secretary to take all necessary actions to support and ensure that COVID‑19 vaccines remain freely available and accessible to everyone in the United States, regardless of income, insurance, or immigration status.
- To reaffirm public‑health benefits of vaccination (reduced severe illness, hospitalizations, deaths) and the importance of equitable access for pandemic control and economic recovery.
Key provisions
- Non‑binding expression of the House’s position that COVID‑19 vaccine access should be free and universally available.
- Calls on federal leaders to take “all necessary actions” to support and ensure free and accessible vaccines (language is broad and does not prescribe specific statutory, funding, or administrative measures).
- Directs transmission of copies of the resolution to: the President, the Speaker of the U.S. House, the Senate Majority Leader, and the Secretary of HHS.
Context and findings cited in the resolution
- Notes the COVID‑19 pandemic’s severe public‑health and economic impacts (citing over one million U.S. deaths).
- Notes vaccines authorized by FDA significantly reduce severe outcomes.
- Raises concerns about unequal access arising from socioeconomic and geographic disparities and the expiration of federal funding that previously guaranteed free vaccines.
- Identifies vaccine misinformation and waning public confidence as risks to uptake.
Who would be affected
- As a resolution, H.R. 135 does not create legal requirements or appropriate funding; it is symbolic and advisory.
- Potentially affects public policy by urging federal action that could influence HHS, federal appropriations, vaccine distribution policy, public messaging, and programs targeting uninsured, low‑income, or immigrant communities.
Procedural / timeline notes
- Introduced September 2, 2025; referred to Committee on Government Operations.
- Because this is a House resolution (not a bill), its immediate effect is to express the chamber’s view and to request the federal officials named to take action; any concrete policy or funding changes would require separate legislation or executive action.
Potential impact and considerations
- Could increase legislative and public pressure for federal reauthorization of vaccine procurement/distribution funds, reinstatement or extension of programs ensuring no‑cost vaccines, or enhanced outreach to underserved communities.
- Lacks specificity: does not identify funding sources, statutory changes, or implementation timelines, so it functions mainly to signal congressional priorities rather than mandate action.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
